Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excellent $TXTM summation you have here Downdraft. Plan the work, and work the plan:
I think so too, it was obvious that quite a few folks didn't have nearly enough $TXTM shares as they would have liked, hence all the ranting and raving
Looks like next set of news could be en route.
Oops, $TXTM is going to a penny, even you said so yourself:
Just Tweeted >>> $TXTM #advisoryfirm #compliance #Cannabislicense ....all about the process.
$TXTM #advisoryfirm #compliance #Cannabislicense ....all about the process.
— Protext Pharma, Inc ($TXTM) (@protxtm) January 22, 2018
WTG, Apostle!! - $$TXTM is lookin' ready to run again here shortly.
$$TXTM ~Very attractive L2 setup this morning...this one could go...all...the...way
***Re-post worthy***
Berkshire -EVEN more relevant DD- with $TXTM
It is my opnion, that the box set up here is now clearly obvious to those with extended level 2 platforms-- huge retail Bidders are trying everything to get 20-21 pps before the next major wave north. THIS NEWS MIGHT TAKE THE WEEKEND TO SINK IN for the WHOLE market...and that will play out quite nicely hear on a huge early Monday move.
NOTE---- I already found enough DD on this company acquired, what they are capable of and WHO THEY CURRENTLY /previously did work for! Frankly- this is extremely cheap for what's now here and the type ICO we have in store here is unique and going to be quite popular in the Pharma ans MJ community
In order to successfully launch an ICO - you MUST HAVE STAR POWER fundraising or venture capital raising connections and skill sets. It is my belief - that that is exactly what $TXTM has just done.
*****They also have positioned themsleves to get the final compliance stages set in motion for the SA license. I suspect when the committee comes back next Monday - they will be thrilled to see this new $TXTM SA Plandai compliance firm Deveolpment. !!! THat is so big. And perhaps not grasped at this current time.
I suspect we will see that massive 60 mil BID move up as this should be testing HOD as the afternoon progresses. Nearly 650K has already been spent on this stock TODAY alone - and all between .0019-.0025 pps. Incredible. It's the strongest Indicator that this price is going much higher as flippers realize there is no more channel to depend on.
What a shame it would be - for folks to lack the foresight of one weeks time - as to the IMPORTANCE of the validating news we have Ben presented today with respect to revenues here AND compliance needs once the SA License has been "obtained" "secured". Just a hunch - but we might even test toward a .003 pps close today
Indeed, the company has good reason to be confident, since they are on a first-name basis with South African government and health officials.
This DD from Sterling says it all for me, this is the real deal:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135755239
How about some geography 101, the Senteeko Estate is located on the total opposite end of South Africa, very far from Cape Town.
Nice try, LOLOLISSIMO
https://www.google.com/maps/place/9+Palm+St,+White+River,+1240,+South+Africa/@-26.8715478,21.6700959,6z/data=!4m5!3m4!1s0x1ee831736fafdf3d:0x62003dee19f39139!8m2!3d-25.3325432!4d31.0084744
Very much looking forward to perusing your DD and thoughts, Sterling.
The magnitude of the Growprocess acquisition is perhaps not easily understood.
I myself have been doing more DD on Tokenized Asset Offerings, and from my early reading, it would appear that TAO-style instruments are expected to dwarf ICO issuances, as venture capitalists and large institutions will adopt this model.
https://www.coindesk.com/goodbye-icos-hello-taos-tokens-will-change-2018/
RE-ALERTING ** $TXTM ** .0021 X .0022 - HUGE #CRYPTOWEED *NEWS OUT*
<<< 1st Alerted @ .0005 >>>
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136393797
Dude...*stop* spamming the board with your opinion presented as fact
Growprocess is expected to bring in to $TXTM $8-10 million dollars for the 2018 grow season alone. That is beyond HUGE MONEY!!
50 million bid...We go higher!!
$TXTM
If peeps must take profits, put your order in on the ask. Trust me, it will all get bought up, and you make more money. #Win-Win
The news will circulate over the weekend, and we could very well see the next update next week.
"Matjaz “Matt” Hrovat, Chief Executive Officer of Growprocess, stated, “We are very excited about this transaction with Protext given the cannabis synergies between our businesses. I have spent the last several years building a successful CBD business and see the significant global opportunity presented by both the blockchain and cannabis industries. We are encouraged by the progress made in the fourth quarter of last year by the Government of South Africa where they officially legalized medical cannabis use. We believe Protext is well positioned to be one of the first companies, if not the first, to receive a Government-issued license to grow cannabis and conduct much-needed pharmaceutical research. With a country of around 55 million citizens, there will be a significant need for a digital ledger track-and-trace technology, which we believe is a perfect foundation for this business. The current global legal cannabis industry does over $7 billion annually, and expected to grow to over $30 billion by 2021, yet there remains a lack of consistent regulations and standardized rules of trade across borders, forcing much of the industry to operate in the shadows and remain outside of the established economic system. As Protext Pharma gears up to commence development of its Phyto-Cannabinoid extract, we want to be at the forefront of ensuring traceability of the product while guaranteeing payment up and down the delivery chain.”
https://globenewswire.com/newsrelease/2018/01/19/1297851/0/en/Protext-Pharma-to-Acquire-Cannabis-Blockchain-Company-Growprocess-Inc.html
Agreed, the folks that didn't bother to read the entire PR are selling due to the "buy the rumor sell the news" mentality.
Well too bad, did you miss that there is more news coming? This is the ground floor:
Wow, check this out. TAO (Tokenized Asset Offering): TBA: PHYTOCOIN
http://growprocess.co/index.php/exec-summary/
*NEWS* - Protext Pharma to Acquire Cannabis Blockchain Company Growprocess, Inc.
Growprocess Expected to Launch ICO-Cannabis-Derivative, Commodity Backed Token Q1 2018
https://globenewswire.com/newsrelease/2018/01/19/1297851/0/en/Protext-Pharma-to-Acquire-Cannabis-Blockchain-Company-Growprocess-Inc.html
BOCA RATON, FL, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Protext Pharma, Inc. (Pinksheets: TXTM ) ("Protext" or "the Company"), a biotech company engaged in the development of pharmaceutical botanical medicines that are formulated with highly-bioavailable plant extracts, today announced that it has signed a binding letter of intent to acquire up to 100% of the ownership in Growprocess, Inc., a blockchain and cannabis compliance advisory firm that has set out to develop a next generation seed-to-sale Blockchain digital ledger platform for the legal cannabis industry. Growprocess’ platform will contain complete “seed-to-sale” information of every cannabis consignment produced. The blockchain-based platform will allow for a transparent tracking and payment solution which will be fully auditable and make clients fully compliant with the various reporting requirements. Additionally, Growprocess is finalizing negotiations and expects to have approximately 3 acres under greenhouse, initially, for commercial hemp production from which CBD will be produced for its commodity backed token expected to launch in early 2018.
Matjaz “Matt” Hrovat, Chief Executive Officer of Growprocess, stated, “We are very excited about this transaction with Protext given the cannabis synergies between our businesses. I have spent the last several years building a successful CBD business and see the significant global opportunity presented by both the blockchain and cannabis industries. We are encouraged by the progress made in the fourth quarter of last year by the Government of South Africa where they officially legalized medical cannabis use. We believe Protext is well positioned to be one of the first companies, if not the first, to receive a Government-issued license to grow cannabis and conduct much-needed pharmaceutical research. With a country of around 55 million citizens, there will be a significant need for a digital ledger track-and-trace technology, which we believe is a perfect foundation for this business. The current global legal cannabis industry does over $7 billion annually, and expected to grow to over $30 billion by 2021, yet there remains a lack of consistent regulations and standardized rules of trade across borders, forcing much of the industry to operate in the shadows and remain outside of the established economic system. As Protext Pharma gears up to commence development of its Phyto-Cannabinoid extract, we want to be at the forefront of ensuring traceability of the product while guaranteeing payment up and down the delivery chain.”
Addressing the proposed ICO token, Mr. Hrovat further explained, “Growprocess has ambitious goals set for 2018, which include the launch of the first ever cannabis-derivative, commodity-backed token anticipated launching in the first quarter. The recent dramatic volatility in the leading cryptocurrencies confirms our belief that tokens backed by a commodity provide certain buffers to that volatility due to the inherent stability of the underlying instrument. In order to back (or commoditize) our token with cannabis and/or CBD production, we are in the process of securing up to three acres of commercial greenhouse hemp production. This production is anticipated to yield approximately ten tons of hemp flowers with a (B2C) value of $8-10 million dollars for the 2018 grow season. Part of our long-term business strategy is to leverage our CBD business into pharmaceutical research. By backing our anticipated ICO not only with CBD production but also the projected medical cannabis production of Protext, we believe we can bring serious value to the offering with significant upside potential.”
Under the terms of the agreement, Protext will acquire 60% of Growprocess for 5,000 shares of Series D Preferred stock with an additional 30,000 shares of Series D Preferred Stock payable based on certain milestones being met by Growprocess. The Company has an option to acquire the remaining 40% during the first six months after closing for an additional $100,000 payable in cash or its equivalent in either preferred or restricted common stock. The Companies anticipate closing to occur around month’s end. Additional details of the Growprocess token, its branding and unique characteristics that have the potential to deliver a financial and funding instrument to a global industry will be made available shortly.
Investors are encouraged to follow Protext using:
YouTube: http://bit.ly/ProtextYouTube
Twitter: https://twitter.com/protxtm
Instagram: https://www.instagram.com/protextm/
About Growprocess:
Growprocess is developing a next generation of seed-to-sale Blockchain ledger platform for the legal cannabis industry, as well as a European-based CBD business. The Company’s platform will enable growers and dispensaries to streamline their operations and optimize their profit margins. Simultaneously, the Company seeks to produce pharmaceutical-grade cannabis products backed by clinical research.
For further information please visit http://growprocess.co and https://twitter.com/growprocessco
About Protext Pharma, Inc.
Protext Pharma operates two wholly owned subsidiaries; Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc. The Company is engaged in the research, clinical testing and commercialization of highly bioavailable botanical products—all-natural ingredients formulated for pharmaceutical applications and produced under pharma-grade conditions. Please visit http://www.protextm.co for further information.
About Plandai Biotechnology SA
Through its wholly owned subsidiary Plandai Biotechnology SA, the Company has the exclusive worldwide license to develop Phytofare® extracts from live plant materials including Phytofare® catechin complex, a highly bioavailable, and clinically proven antioxidant complex produced from live green tea leaves. Phytofare® can deliver a therapeutic level of catechins, which function as powerful antioxidants, to the system where they remain active for over 24 hours.
About Cannabis Biosciences
The Company is actively pursuing government licensing that will allow it to use its proprietary processing and extraction technology to commence investigations and produce a full-profile cannabis extract, one that contains both CBD and the precursor acid form of THC (THC-A and THC-B) found in live cannabis plant. The Company's investigations will be designed to show that the Cannabis Biosciences extraction process, which will use live leaf and low temperatures to extract the phyto-chemicals, should leave the acid forms of THC intact, resulting in a non-psychoactive extract with full medicinal potential and having the heightened bioavailability of other Phytofare® extracts.
Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. The company disclaims any obligation to update information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.
$TXTMonster ask slaps comin' in. News must be HUGE!!
Too funny, lol, 'what a bummer' $TXTM is only up 72% today.
I bet you're a hoot at holidays
Drop the curtain, cue the music >>> $TXTM prep'n for Deuceville thunder & lightning :
Powerhour could get interesting. A break of .0020 could push $TXTM into hyperspace, IMO.
What did I tell ya, a little more pay-tience was needed. Those that bought yesterday's weakness are grinning from ear to ear
Someone will rue the day they sold $TXTM at .0015 shortly
Telling you folks, we have a winner here. Been pounding the table for months.
Even better Whynot buddy, I just called a few other buddies.
Told them this may be the final countdown before launch. Buy and hold for maximum ROI.
#pay-tiencepays
$TXTMemento: "To the $victors belong the spoils"
-Andrew Jackson
$TXTMission Control dropping the dead weight here.
$$$Rocket boosters about to ignite, IMO.
There most certainly is a club, it's called Club Med.
Those of us with the tenacity to see $TXTM through to fruition will be lifelong members
There always has been, always will be, and there always is a 'pay' in PAY-TIENCE.
Pay-tience about to pay off in spades with $TXTM.
Yep same here, been accumulating $TXTM for months now.
This is one of the few OTC stocks, where the required patience to see it to fruition will be rewarded beyond one's dreams.
$Dream Bigly$
Likewise Doog, have a fantastic long weekend!
Have fun and rock out, but make sure you're all good and rested, as next week we are prep'n to go into space with $TXTM, by the looks of things. Get that astronaut gear ready.
Agreed Raven, $$TXTM is being accumulated by savvy traders/investors for a reason.
The investment community has just recently begun to realize the tremendous potential inherent within our hidden cannabis gem.
I too think we're closer than ever to the next massive leg up.
Nice find, yup here is the link & tweet:
TXTM .0012 X .0013 **Hot Marijuana Stock To Watch** We expect a tremendous year for 2018 as the company positions itself to be a major global player. Stay tuned! Potential to .02 cents projected. #MARIJUANA #HEMP #SOUTHAFRICA $TXTM pic.twitter.com/cnqrVFDYU8
— PennyStockGeeks (@PennyStockGeeks) January 10, 2018
$$TXTMurciélago gearing up for the Deuceville Grand Prix!!!
+ .0004 , + 40.00%
Volume: 96,326,613
@ 2:25 EST
https://ih.advfn.com/stock-market/USOTC/protext-mobility-inc-TXTM/trades
On this you speak 100% truth, Doog:
$IFXYielding huge gains >>> A classic case of where perseverance paid off